ALLMedicine™ Acute Erythroid Leukemia Center
Research & Reviews 36 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630502
Blood Cancer Journal; Reichard KK, Tefferi A et. al.
Nov 4th, 2022 - Pure erythroid leukemia (PEL), also known as acute erythroid leukemia (AEL), is recognized as a distinct morphologic entity by both the 2016 and 2022 World Health Organization (WHO) classification system. By contrast, the 2022 International Consen...
https://doi.org/10.1016/S2152-2650(22)01229-0
Clinical Lymphoma, Myeloma & Leukemia; Friske J, Fukuda Y et. al.
Sep 28th, 2022 - Acute erythroid leukemia (AEL) is a disease of erythroid lineage that commonly exhibits TP53 mutations, a complex karyotype, and poor prognosis irrespective of currently available therapies. To identify AEL dependencies and novel therapeutic targe...
https://doi.org/10.1007/s11912-021-01060-8
Current Oncology Reports; Weinberg OK, Arber DA
Apr 21st, 2021 - Acute erythroleukemia (AEL) is a rare form of acute myeloid leukemia recognized by erythroblastic proliferation. Many controversies remain around diagnosis influencing prognostic and therapeutic implications relating to this unique leukemia subset...
https://doi.org/10.1182/blood.2020010544
Blood Zhang JP, Cheng T
Mar 26th, 2021 - Modeling acute erythroid leukemia via CRISPR.|2021|Zhang JP,Cheng T,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995291
Blood Iacobucci I, Qu C et. al.
Jan 30th, 2021 - Acute erythroid leukemia (AEL) is characterized by a distinct morphology, mutational spectrum, lack of preclinical models, and poor prognosis. Here, using multiplexed genome editing of mouse hematopoietic stem and progenitor cells and transplant a...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT02861651
Aug 10th, 2016 - Acute erythroid leukemia (AEL) is a morphologically distinct, infrequent (o5%) acute myeloid leukemia (AML) designed as M6 in the French- American-British (FAB) classification. The World Health Organization classification recognizes two subclasses...
